Sensory Rehabilitation in Chemo Induced Peripheral Neuropathy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssaf-Harofeh Medical Center

About this trial

This study is a cross-over RCT evaluating the effectiveness of 3 sessions a week apart of explicit sensory retraining to the lower extremities in individuals with CIPN versus usual care. The primary outcome measures are TNAS for subjective symptoms, VAS for pain and TUG for mobility. Additional outcome measures are FABS for balance, sensory assessments - monofilaments for touch threshold, LEPT for proprioception, a home exercise log and a satisfaction questionnaire.

Eligibility criteria

Qualifiers

CIPN by self-report (present or absent) > 3 months after last chemotherapy treatment

age > 18.

Disqualifiers

Pre-chemotherapy neuropathy/ sensory impairment

recurrent falls prior to chemotherapy (more than 2 per year)

CNS involvement

not ambulatory before chemotherapy

Trial design

Treatments tested in this trial

  • Explicit Sensory Retraining for the lower extremities
  • no treatment

Treatment groups

27 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Assaf-Harofeh Medical Center

Lead sponsor

Zefat Academic College

Collaborator